Skip to content

Essential Oils for Electrocautery

Utility of Aromatherapy in Reducing Burnt Flesh Smell, Decreasing Intraoperative Anxiety, and Improving the Patient's Overall Experience During Cutaneous Surgical Procedures: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04260867
Enrollment
111
Registered
2020-02-07
Start date
2020-12-22
Completion date
2025-12-31
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

The purpose of this study is to assess whether essential oil aromatherapy could improve or eliminate the smell of burnt flesh from electrocautery and subsequently mitigate patient anxiety and discomfort during dermatologic skin surgery. This is a randomized clinical trial. Approximately 210 electrocautery participants will be randomized to receive sham control/no aromatherapy or aromatherapy. Patients will be asked to complete a questionnaire after completion of the procedure to assess their experience. This study was a pilot study designed to determine the feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be invited and considered for enrollment.

Interventions

Those randomized to the treatment group will have containers filled with the essential oil of their choice.

OTHERNo Essential Oil

Those randomized to the control group will then be given empty single-use handheld aromatherapy containers containing no essential oil.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. \>18 years of age 2. Receiving same day cutaneous surgical procedure that requires electrocautery per protocol 3. In good general health as assessed by the investigator 4. Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study

Exclusion criteria

1. Surgery site incompatible with the patient holding a handheld aromatherapy device (physician discretion) 2. Subject unwilling to sign an IRB approved consent form 3. Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible

Design outcomes

Primary

MeasureTime frameDescription
Self-reported perceptions of cautery smell on a 4-point likert scaleImmediately after surgeryThis is a patient-reported questionnaire about perceptions of smell.
Patient reported anxiety State-Trait Anxiety Inventory (STAI-6)Immediately after surgeryPatient perioperative anxiety will be reported on the 6-item shortform of the State-Trait Anxiety Inventory (STAI-6) directly after procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026